Evidence map›Paper›PMID 35713728›Full record

ArticleCellular and molecular life sciences : CMLS2022

Mechanisms of chronic alcohol exposure-induced aggressiveness in cellular model of HCC and recovery after alcohol withdrawal.

Constance Marié, Grégory Fouquet, Anoïsia Courtois, Rabbind Singh Amrathlal, Nicolas Jankovsky, Hakim Ouled-Haddou, Riad Tebbakha, Hicham Bouhlal, Éric Nguyen-Khac, Mickaël Naassila and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Constance MariéGroupe de Recherche Sur L'Alcool et Les Pharmacodépendances INSERM UMR1247, Centre Universitaire de Recherche en Santé CURS, Université de Picardie Jules Verne, Avenue Laennec, 80051, Amiens, France.
Grégory FouquetGroupe de Recherche Sur L'Alcool et Les Pharmacodépendances INSERM UMR1247, Centre Universitaire de Recherche en Santé CURS, Université de Picardie Jules Verne, Avenue Laennec, 80051, Amiens, France.
Anoïsia CourtoisGroupe de Recherche Sur L'Alcool et Les Pharmacodépendances INSERM UMR1247, Centre Universitaire de Recherche en Santé CURS, Université de Picardie Jules Verne, Avenue Laennec, 80051, Amiens, France.
Rabbind Singh AmrathlalCentre for Genomics, Jiwaji University, Gwalior, 474011, India.
Nicolas JankovskyLaboratoire HEMATIM EA4666, Centre Universitaire de Recherche en Santé CURS, Université de Picardie Jules Verne, Amiens, France.
Hakim Ouled-HaddouLaboratoire HEMATIM EA4666, Centre Universitaire de Recherche en Santé CURS, Université de Picardie Jules Verne, Amiens, France.
Riad TebbakhaService Anatomie Pathologie-Tumorothèque de Picardie, Centre Hospitalier Universitaire Nord, Amiens, France.
Hicham BouhlalGroupe de Recherche Sur L'Alcool et Les Pharmacodépendances INSERM UMR1247, Centre Universitaire de Recherche en Santé CURS, Université de Picardie Jules Verne, Avenue Laennec, 80051, Amiens, France.
Éric Nguyen-KhacGroupe de Recherche Sur L'Alcool et Les Pharmacodépendances INSERM UMR1247, Centre Universitaire de Recherche en Santé CURS, Université de Picardie Jules Verne, Avenue Laennec, 80051, Amiens, France.
Mickaël Naassila *Groupe de Recherche Sur L'Alcool et Les Pharmacodépendances INSERM UMR1247, Centre Universitaire de Recherche en Santé CURS, Université de Picardie Jules Verne, Avenue Laennec, 80051, Amiens, France.
Ingrid MarcqGroupe de Recherche Sur L'Alcool et Les Pharmacodépendances INSERM UMR1247, Centre Universitaire de Recherche en Santé CURS, Université de Picardie Jules Verne, Avenue Laennec, 80051, Amiens, France. ingrid.marcq@u-picardie.fr.ORCID http://orcid.org/0000-0002-4031-224X
Inserm · FRCentre Hospitalier Universitaire Amiens-Picardie · FRJiwaji University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alcohol-related liver disease is the most prevalent chronic liver disease worldwide, accounting for 30% of hepatocellular carcinoma (HCC) cases and HCC-specific deaths. However, the knowledge on mechanisms by which alcohol consumption leads to cancer progression and its aggressiveness is limited. Better understanding of the clinical features and the mechanisms of alcohol-induced HCC are of critical importance for prevention and the development of novel treatments. Early stage Huh-7 and advanced SNU449 liver cancer cell lines were subjected to chronic alcohol exposure (CAE), at different doses for 6 months followed by 1-month alcohol withdrawal period. ADH activity and ALDH expression were much lower in SNU449 compared with Huh-7 cells and at the 270 mM dose, CAE decreased cell viability by about 50% and 80%, respectively, in Huh-7 and SNU449 cells but induced mortality only in Huh-7 cells. Thus, Huh-7 may be more vulnerable to ethanol toxicity because of the higher levels of acetaldehyde. CAE induced a dose-dependent increase in cell migration and invasion and also in the expression of cancer stem cells markers (CD133, CD44, CD90). CAE in Huh-7 cells selectively activated ERK1/2 and inhibited GSK3β signaling pathways. Most of the changes induced by CAE were reversed after alcohol withdrawal. Interestingly, we confirmed the increase in CD133 mRNA levels in the tumoral tissue of patients with ethanol-related HCC compared to other HCC etiologies. Our results may explain the benefits observed in epidemiological studies showing a significant increase of overall survival in abstinent compared with non-abstinent patients.

Indexed as

AlcoholismCarcinoma, HepatocellularLiver NeoplasmsSubstance Withdrawal SyndromeCell Line, TumorEthanolHumansEthanolAlcoholCancerous stem cellLiver cancerWithdrawal

Identifiers

PMID35713728
PMCPMC9205837
OpenAlexW4283033995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.